#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 4

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Chronic obstructive pulmonary disease

Recruiting

Investigational

Efficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:LUNSEKIMIG

Contact Research Centre

Bladder cancer

Recruiting

Registered drugNo placebo

Study of Enfortumab Vedotin and Pembrolizumab for Bladder Preservation in Patients with Muscle‑Invasive Bladder Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Enfortumab Vedotin

Contact Research Centre

Amyotrophic lateral sclerosis

Recruiting

Investigational

Safety and Tolerability of Intrathecal TRCN-1023 in Adults with Amyotrophic Lateral Sclerosis (ALS) – Randomized Placebo‑Controlled Phase 1/2 Trial

Investigational

Germany

Participants:18–64 years · 65+ years

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drug

Study of MK-1084 plus durvalumab versus placebo plus durvalumab in patients with locally advanced KRAS G12C‑mutant non‑small cell lung cancer after chemoradiotherapy

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Vitiligo

Recruiting

Investigational

Phase IIb Randomized, Double‑Blind Study of GIA632 in Adults with Nonsegmental Vitiligo

Investigational

Germany

Participants:18–64 years · 65+ years

Contact Research Centre

Non-small cell lung cancer stage III

Recruiting

Registered drugNo placebo

Pumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Chronic spontaneous urticaria

Recruiting

InvestigationalNo placebo

Remibrutinib in Chronic Spontaneous Urticaria for Patients Who Benefited from a Previous Remibrutinib Trial

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Remibrutinib

Contact Research Centre

Colorectal cancer metastatic

Recruiting

Registered drug

INCA33890 With Standard Chemotherapy and Bevacizumab in First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Non-small cell lung cancer+1

Recruiting

Registered drugNo placebo

Pumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Asthma

Recruiting

Investigational

GB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents

Investigational

Germany

Participants:0–17 years · 18–64 years · 65+ years

Contact Research Centre

Ductal adenocarcinoma of pancreas

Recruiting

InvestigationalNo placebo

A study of daraxonrasib (RMC-6236) compared to observation in patients with resected pancreatic cancer following chemotherapy

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:(12M)-(1S,2S)-N-((63S,4S,Z)-11-ETHYL-12-(2-((S)-1-METHOXYETHYL)-5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)-10,10-DIMETHYL-5,7-DIOXO-61,62,63,64,65,66-HEXAHYDRO-11H-8-OXA-2(4,2)-THIAZOLA-1(5,3)-INDOLA-6(1,3)-PYRIDAZINACYCLOUNDECAPHANE-4-YL)-2-METHYLCYCLOPROPANE-1-CARBOXAMIDE

Contact Research Centre

Hepatocellular carcinoma

Recruiting

Registered drugNo placebo

A study of pumitamig and ipilimumab in patients with advanced or unresectable liver cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ipilimumab

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.